Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
Evaluation of atrial conduction properties and atrial arrhythmia propensity in vitiligo patients
Aims: Vitiligo is a skin condition characterized by melanocyte loss. It is thought to have a robust association with various systemic and metabolic disorders, such as insulin resistance, atherosclerotic cardiovascular disease, and metabolic syndrome. Atrial fibrillation (AF) is a prevalent disorder in clinical practice and appears to be predictable by atrial electromechanical delay (EMD). This study aimed to detect atrial conduction time through tissue Doppler echocardiography, a non-invasive method used for patients with vitiligo.
Methods: We conducted this study with 32 patients diagnosed with generalized vitiligo and 38 age- and sex-matched controls. We evaluated all participants' blood samples, including neutrophil/lymphocyte ratio (NLR), high-sensitivity C-reactive protein (hs-CRP), and other laboratory parameters. Then, we calculated atrial EMD, intra-atrial EMD, and left atrial EMD.
Results: We found neutrophil count, NLR levels, and hs-CRP levels to be significantly higher in the vitiligo group (6 ± 1.4 vs. 4.5 ± 2.3, p = 0.001; 3.5 ± 1.4 vs. 2.5 ± 1.9, p = 0.024; 6.2 ± 1.9 mg/dl vs. 4.1 ± 1.3 mg/dl, p < 0.001, respectively). In addition, inter-atrial and intra-atrial EMD were significantly higher in the vitiligo group compared to the control group (36.3 ± 8.5 vs. 24.2 ± 10.8, p < 0.001; 18.1 ± 8.3 vs. 10.9 ± 5.8, p < 0.001, respectively). Finally, left atrial EMD was higher in the vitiligo group, but we could not reach statistical significance (15.3 ± 6.9 vs. 13.2 ± 7.2, p = 0.33).
Conclusion: We concluded that intra-atrial EMD and inter-atrial EMD were significantly prolonged in the vitiligo patients. Our results suggest that vitiligo patients are at risk for atrial fibrillation.

1. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: acomprehensive overview Part I. Introduction, epidemiology, qualityof life, diagnosis, differential diagnosis, associations, histopathology,etiology, and work-up. Journal of the American Academy of Dermatology.2011;65(3):473-491.
2. Ataş H, G&ouml;n&uuml;l M. Increased risk of metabolic syndrome in patientswith vitiligo. Balkan Medical Journal. 2017; 34(3):219-225.
3. Tanacan E, Atakan N. Higher incidence of metabolic syndromecomponents in vitiligo patients: a prospective cross-sectional study.Anais Brasileiros de Dermatologia. 2020;95(2):165-172.
4. Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571-592.
5. Picardo M, Dell&rsquo;Anna ML, Ezzedine K, et al. Vitiligo. Nature reviewsdisease primers. 2015;1:15011.
6. January CT, Wann LS, Alpert JS, et al: 2014 AHA/ACC/HRS guidelinefor the management of patients with atrial fibrillation: a report of theamerican college of cardiology/american heart association task forceon practice guidelines and the heart rhythm society. Journal of theAmerican College of Cardiology. 2014;64: e1-76.
7. Deniz A, Sahiner L, Aytemir K, et al. Tissue Doppler echocardiographycan be a useful technique to evaluate atrial conduction time. CardiologyJournal. 2012;19(5):487-493.
8. Dogdu O, Yarlioglues M, Kaya MG, et al. Assessment of atrialconduction time in patients with systemic lupus erythematosus. Journalof Investigative Medicine. 2011; 59(2):281-286.
9. Tasal A, Guvenc TS, Kul S, Erdogan E et al. Atrial conductionabnormalities in patients with psoriasis vulgaris. Kardiologia Polska.2015;73(8):637-643.
10. Duman H, Dilek N, Değirmenci H, ert al. Decreased left atrial strainparameters are associated with prolonged total atrial conduction timein lichen planus. Interventional Medicine and Applied Science. 2018;10(3):150-156.
11. Lotti T, D&rsquo;Erme AM. Vitiligo as a systemic disease. Clinics in Dermatology.2014;32:430-434.
12. Randhawa M, Huff T, Valencia JC, et al. Evidence for the ectopicsynthesis of melanin in human adipose tissue. The FASEB Journal.2009;23(3):835-843.
13. Morrone A, Picardo M, De Luca C, et al. Catecholamines and vitiligo.Pigment Cell Research. 1992;5:65-69.
14. Solak B, Dikicier BS, Cosansu NC, Erdem T. Neutrophil to lymphocyteratio in patients with vitiligo. Postepy Dermatologii i Alergologii.2017;34(5):468-470.
15. Demirbaş A, Elmas &Ouml;F, Atasoy M, T&uuml;rsen &Uuml;, Lotti T. Can monocyte toHDL cholesterol ratio and monocyte to lymphocyte ratio be markers forinflammation and oxidative stress in patients with vitiligo? A preliminarystudy. Archives of Dermatological Research. 2021;313:491-498.
16. Grimes PE, Morris R, Avaniss-Aghajani E, et al. Topical tacrolimustherapy for vitiligo: therapeutic responses and skin messenger RNAexpression of proinflammatory cytokines. Journal of the AmericanAcademy of Dermatology. 2004;51(1):52-61.
17. Cui QQ, Zhang W, Wang H, et al. Assessment of atrial electromechanicalcoupling and influential factors in nonrheumatic paroxysmal atrialfibrillation. Clinical Cardiology. 2008;31(2):74-78.
18. Roshanali F, Mandegar MH, Yousefnia MA, Alaeddini F, Saidi B.Prevention of atrial fibrillation after coronary artery bypass grafting viaatrial electromechanical interval and use of amiodarone prophylaxis.Interactive CardioVascular and Thoracic Surgery. 2009;8(4):421-425.
19. Bakirci EM, Demirtas L, Degirmenci H, et al. Relationship of the totalatrial conduction time to subclinical atherosclerosis, inflammation andechocardiographic parameters in patients with type 2 diabetes mellitus.Clinics (Sao Paulo). 2015;70(2):73-80.
20. Ozer N, Yavuz B, Can I, et al. Doppler tissue evaluation of intra-atrialand interatrial electromechanical delay and comparison with P-wavedispersion in patients with mitral stenosis. The Journal of the AmericanSociety of Echocardiography. 2005; 18(9):945-948.
21. Calapkorur B, Kelesoglu S, Sarli B, et al. Atrial electromechanical delayis impaired in patients with psoriasis. Medical Principles and Practice.2015;24(1):30-35.
22. Efe TH, Cimen T, Ertem AG, et al. Atrial electromechanical propertiesin inflammatory bowel disease. Echocardiography. 2016;33(9):1309-1316.
23. Deniz A, Yavuz B, Aytemir K, et al. Intra-left atrial mechanical delaydetected by tissue Doppler echocardiography can be a useful marker forparoxysmal atrial fibrillation. Echocardiography. 2009;26(7):779-784.
24. Chang CM, Wu TJ, Zhou S, et al. Nerve sprouting and sympathetichyperinnervation in a canine model of atrial fibrillation produced byprolonged right atrial pacing. Circulation. 2001;103(1):22-25.
25. Jayachandran JV, Sih HJ, Winkle W, et al. Atrial fibrillation produced byprolonged rapid atrial pacing is associated with heterogeneous changesin atrial sympathetic innervation. Circulation. 2000;101(10):1185-1191.
26. Kim KB, Rodefeld MD, Schuessler RB, Cox JL, Boineau JP. Relationshipbetween local atrial fibrillation interval and refractory period in theisolated canine atrium. Circulation. 1996;94(11):2961-2967.
27. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervationcreates substrate for sustained atrial fibrillation. Circulation.1998(23);98:2608-2614.
28. Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation.Journal of the American College of Cardiology. 2012;60(22): 2263-2270.
29. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillationis associated with local cardiac platelet activation and endothelialdysfunction. Journal of the American College of Cardiology. 2008;51(18):1790-1793.
30. Scott L Jr, Li N, Dobrev D. Role of inflammatory signaling in atrialfibrillation. International Journal of Cardiology. 2019;287:195-200.
Volume 1, Issue 4, 2023
Page : 66-70